Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care
Sona Ciernikova, Aneta Sevcikova, Ľuboš Drgoňa, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188990-188990
Closed Access | Times Cited: 23

Showing 23 citing articles:

Exploiting bacteria for cancer immunotherapy
Seong Young Kwon, Hien Thi-Thu Ngo, Jinbae Son, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 8, pp. 569-589
Closed Access | Times Cited: 47
Gut microbial metabolites in lung cancer development and immunotherapy: Novel insights into gut-lung axis
Xinpei Li, Shijie Shang, Meng Wu, et al.
Cancer Letters (2024) Vol. 598, pp. 217096-217096
Closed Access | Times Cited: 11
Exploring the microbiome-gut-testis axis in testicular germ cell tumors
Sona Ciernikova, Aneta Sevcikova, Michal Mego
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access | Times Cited: 1
Synergistic Interactions Between Probiotics and Anticancer Drugs: Mechanisms, Benefits, and Challenges
Babak Pezeshki, Hussein T. Abdulabbas, Asma M. Alturki, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access | Times Cited: 1
Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug
Alice Njolke Mafe, Dietrich Büsselberg
Biomedicines (2025) Vol. 13, Iss. 2, pp. 422-422
Open Access | Times Cited: 1
The connection between aging, cellular senescence and gut microbiome alterations: A comprehensive review
D.S. Jang, J W Shin, Eunha Shim, et al.
Aging Cell (2024) Vol. 23, Iss. 10
Open Access | Times Cited: 6
Modulation of Intestinal Flora: a Novel Immunotherapeutic Approach for Enhancing Thyroid Cancer Treatment
Wei-Qiang Huang, Tao Jiang, Jiaxuan He, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Unlocking the Code of Innovation: TRIZ Theory’s Blueprint for Precision Medicine Breakthroughs
Raymond John Schmidt
(2025), pp. 3-18
Open Access
Operationalizing Team Science at the Academic Cancer Center Network to Unveil the Structure and Function of the Gut Microbiome
Kevin McDonnell
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 2040-2040
Open Access
Research progress on fecal microbiota transplantation in tumor prevention and treatment
Yajun Wu, Zike Lei, Qingming Wu, et al.
Open Life Sciences (2025) Vol. 20, Iss. 1
Open Access
Optimizing Cancer Treatment Through Gut Microbiome Modulation
Kyuri Kim, Mingyu Lee, Yoojin Shin, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1252-1252
Open Access
Dermatologic toxicities related to cancer immunotherapy
Yosra Vaez-Gharamaleki, Mohammad Amin Akbarzadeh, Farhad Jadidi‐Niaragh, et al.
Toxicology Reports (2025), pp. 102021-102021
Open Access
Microbiome in Cancer Development and Treatment
Sona Ciernikova, Aneta Sevcikova, Beáta Mladosievičová, et al.
Microorganisms (2023) Vol. 12, Iss. 1, pp. 24-24
Open Access | Times Cited: 10
Postbiotic butyrate: role and its effects for being a potential drug and biomarker to pancreatic cancer
Abinaya Elango, Vineeta Debbie Nesam, Padmaja Sukumar, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 4
Closed Access | Times Cited: 3
Bifidobacterium animalis subsp. lactis HN019 live probiotics and postbiotics: production strategies and bioactivity evaluation for potential therapeutic properties
Sergio D’ambrosio, Azza Dabous, Saba Sadiq, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 2
Targeting the gut and tumor microbiome in cancer resistance
Sona Ciernikova, Aneta Sevcikova, Michal Mego
AJP Cell Physiology (2024) Vol. 327, Iss. 6, pp. C1433-C1450
Closed Access | Times Cited: 2
Prebiotic stachyose inhibits PRDX5 activity and castration-resistant prostate cancer development
Rong Wang, Pan Yu, Lan Zhang, et al.
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134844-134844
Closed Access | Times Cited: 1
Human and gut microbiota synergy in a metabolically active superorganism: a cardiovascular perspective
Matteo Antonio Russo, Matteo Puccetti, Claudio Costantini, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 1
The Link Between the Gut Microbiome and Bone Metastasis
Aneta Sevcikova, Monika Martiniaková, Radoslav Omelka, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12086-12086
Open Access | Times Cited: 1
Insights into the Relationship Between the Gut Microbiome and Immune Checkpoint Inhibitors in Solid Tumors
Sona Ciernikova, Aneta Sevcikova, Mária Novisedláková, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4271-4271
Open Access | Times Cited: 1
Safety and efficacy of fecal microbiota transplantation for cytotoxic chemotherapy– induced diarrhea management in patients with colorectal cancer: a single-arm clinical trial
Mohammed Alnaggar, Mueataz A. Mahyoub, Wen Jun Cheng, et al.
Research Square (Research Square) (2024)
Open Access
Microbial Allies: How Gut Microbiota Influence the Effectiveness of Immune Checkpoint Inhibitors
Hamed Azhdari Tehrani, Amir‐Mohammad Yousefi, Sina Salari, et al.
Iranian Journal of Blood and Cancer (2024) Vol. 16, Iss. 3, pp. 70-85
Closed Access
Beyond probiotics: postbiotics sensitize cancer cells to immune checkpoint inhibitors
Weici Liu, Zheshun Pi, Wenjun Mao
Trends in cancer (2023)
Closed Access | Times Cited: 1
Page 1

Scroll to top